Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S. CDC Says Delivered 580,893,145 Doses Of Covid-19 Vaccine As Of Dec 3

12/03/2021 | 03:16pm EST

Dec 3 (Reuters) - U.S. CDC:

* U.S. CDC SAYS DELIVERED 580,893,145 DOSES OF COVID-19 VACCINE AS OF DEC 3 VERSUS 578,263,565 DOSES AS OF DEC 2

* U.S. CDC SAYS ADMINISTERED 466,348,132 DOSES OF COVID-19 VACCINE AS OF DEC 3 VERSUS 464,445,580 DOSES AS OF DEC 2

* U.S. CDC SAYS 234,743,864 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF DEC 3 VERSUS 234,269,053 INDIVIDUALS AS OF DEC 2

* U.S. CDC SAYS 198,211,641 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF DEC 3 VERSUS 197,838,728 INDIVIDUALS AS OF DEC 2

* U.S. CDC SAYS AS OF DECEMBER 3, 44,035,293 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021


ę Reuters 2021
All news about MODERNA, INC.
04:31aGermany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1
RE
01/24Chile to purchase 2 million Moderna COVID-19 vaccine doses
RE
01/24LEIDEN UNIVERSITY : mRNA boosters are the most effective upon receiving Janssen vaccinatio..
AQ
01/24INSIDER SELL : Moderna
MT
01/24NORTH AMERICAN MORNING BRIEFING : Stocks Seen -3-
DJ
01/21Moderna's Valuation Has Come 'Back to Earth,' Become More Reasonable, BofA Securities S..
MT
01/21Boosters provide 'added protection' against Omicron -CDC
RE
01/21Small children getting less sick from Omicron; Genetic mutation protects against severe..
RE
01/21Booster shots needed against omicron, CDC studies show
AQ
01/21U.S. studies highlight the need for COVID boosters to fight Omicron
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 644 M - -
Net income 2021 11 173 M - -
Net cash 2021 10 558 M - -
P/E ratio 2021 5,92x
Yield 2021 -
Capitalization 63 777 M 63 777 M -
EV / Sales 2021 3,02x
EV / Sales 2022 1,97x
Nbr of Employees 1 300
Free-Float -
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 157,30 $
Average target price 266,88 $
Spread / Average Target 69,7%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-38.07%63 777
LONZA GROUP AG-19.59%49 711
IQVIA HOLDINGS INC.-13.62%46 556
SEAGEN INC.-16.20%23 689
ICON PUBLIC LIMITED COMPANY-17.32%20 842
CELLTRION, INC.-15.91%19 358